Marc
Ensign
Forensic CMO

Marc Ensign is a renowned marketing expert, prolific storyteller, and accomplished musician.

After spending more than a decade playing bass with the Broadway Show Rent, Marc discovered that he had a talent for turning great ideas into even better marketing. I mean, how else does a kid with no experience and no connections pass up thousands of other musicians to land the most coveted gig in New York City?

He's really that good.

When his stint on Broadway came to a close, he (temporarily) hung up his bass and built a successful digital marketing agency to help companies compete in otherwise impossible industries to break into. This approach caught the attention of Fortune 500 Companies, Celebrities, Athletes, and Entertainers.

But eventually, that sort of thing gets boring, so Marc moved on.

Now, leveraging over twenty years in the marketing industry, Marc has started a unique agency focusing on what he coined "forensic marketing." A methodology of dissecting every marketing dollar a company spends in order to cut waste and uncover hidden opportunities before creating a new strategy and building the right team to implement that strategy. Much like a forensic accountant might do for finances.

And that's when Forensic CMO was born.

As the Chief Forensic CMO, Marc and his team have saved companies hundreds of thousands a month in wasted spend, ineffective vendors, and missed opportunities.

That must be a good thing because business is booming.

Yet, none of this would be possible if it wasn't for Marc's incredibly understanding wife, who has been on this rollercoaster for 21 years and counting. Together, they have two kids. Bella is 19 and attending FSU with a major in journalism, and Zach is 15 and is studying to be a game designer.



Join Us for the Next
Board of Advisors Event!
A member of our Concierge Team will promptly assist you with the next steps
THINK YOU
ARE A GOOD
INTERVIEW WITH ME FOR A SEAT AT THE BOARD
We will invest 20 to 30 minutes together by phone.
RSVP REQUIRED
 
Q2 - May 2024